• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全内镜冠状动脉旁路移植术:当前证据的荟萃分析。

Totally endoscopic coronary artery bypass surgery: A meta-analysis of the current evidence.

机构信息

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, United States.

Samuel J. Wood Library & C.V. Starr Biomedical Information Center, Weill Cornell Medicine, New York, NY, United States.

出版信息

Int J Cardiol. 2018 Jun 15;261:42-46. doi: 10.1016/j.ijcard.2017.12.071.

DOI:10.1016/j.ijcard.2017.12.071
PMID:29657055
Abstract

BACKGROUND

Totally endoscopic coronary artery bypass (TECAB) has emerged as an alternative to other minimally invasive techniques. However, limited TECAB results are available to date. The purpose of this systematic review is to examine the existing literature to give an objective estimate of the outcomes of TECAB using a meta-analytical approach.

METHODS

A comprehensive online review was performed in Ovid MEDLINE®, Ovid EMBASE and The Cochrane Library from 2000 to July 2017. Eligible studies included single arm TECAB studies as well as comparative studies (TECAB vs minimally invasive direct coronary artery bypass (MIDCAB)). Pooled event rates and odds ratios (ORs) for operative mortality, perioperative myocardial infarction (MI), perioperative stroke, graft patency and repeat revascularization were estimated. Single arm and pairwise comparisons were performed.

RESULTS

Seventeen single arm TECAB articles (3721 patients, weighted mean follow-up 3.3years) were included. The pooled event rate was 0.80% (95%CI: 0.60-1.2%) for operative mortality, 2.28% (95%CI: 1.7-3%) for perioperative MI, 1.50% (95%CI: 1.1-2.0%) for perioperative stroke, 2.99% (95%CI: 1.6-5.4%) for repeat revascularization and 94.8% (95%CI: 89.3-97.5%) for early graft patency (weighted mean follow-up 10.1months). On pairwise meta-analysis 376 patients (263 TECAB and 113 MIDCAB) were included. No difference in operative mortality (OR=0.25, 95%CI: 0.02-2.83), perioperative MI (OR=3.09, 95%CI: 0.37-26.12) or perioperative stroke (OR=1.33, 95%CI: 0.17-10.26) was found between the two techniques.

CONCLUSIONS

TECAB has an acceptably low operative risk and a good early patency rate. The incidence of perioperative MI requires further investigation. The dearth of data comparing TECAB to open approaches compels the need for future comparative trials.

摘要

背景

全内窥镜冠状动脉旁路移植术(TECAB)已成为其他微创技术的替代方法。然而,目前有限的 TECAB 结果。本系统评价的目的是通过荟萃分析方法,检查现有文献,对 TECAB 的结果进行客观评估。

方法

从 2000 年到 2017 年 7 月,在 Ovid MEDLINE®、Ovid EMBASE 和 The Cochrane Library 中进行了全面的在线检索。合格的研究包括单臂 TECAB 研究和对照研究(TECAB 与微创直接冠状动脉旁路移植术(MIDCAB))。估计手术死亡率、围手术期心肌梗死(MI)、围手术期卒中、移植物通畅率和再次血运重建的合并事件率和优势比(ORs)。进行了单臂和配对比较。

结果

纳入了 17 篇单臂 TECAB 文章(3721 例患者,加权平均随访 3.3 年)。手术死亡率的合并发生率为 0.80%(95%CI:0.60-1.2%),围手术期 MI 为 2.28%(95%CI:1.7-3%),围手术期卒中为 1.50%(95%CI:1.1-2.0%),再次血运重建为 2.99%(95%CI:1.6-5.4%),早期移植物通畅率为 94.8%(95%CI:89.3-97.5%)(加权平均随访 10.1 个月)。在成对荟萃分析中,纳入了 376 例患者(263 例 TECAB 和 113 例 MIDCAB)。两种技术之间的手术死亡率(OR=0.25,95%CI:0.02-2.83)、围手术期 MI(OR=3.09,95%CI:0.37-26.12)或围手术期卒中(OR=1.33,95%CI:0.17-10.26)无差异。

结论

TECAB 具有可接受的低手术风险和良好的早期通畅率。围手术期 MI 的发生率需要进一步调查。缺乏比较 TECAB 与开放方法的数据,这迫使需要未来进行比较试验。

相似文献

1
Totally endoscopic coronary artery bypass surgery: A meta-analysis of the current evidence.全内镜冠状动脉旁路移植术:当前证据的荟萃分析。
Int J Cardiol. 2018 Jun 15;261:42-46. doi: 10.1016/j.ijcard.2017.12.071.
2
Comparative Analysis of Perioperative and Mid-Term Results of TECAB and MIDCAB for Revascularization of Anterior Wall.全胸腔镜冠状动脉搭桥术(TECAB)与微创冠状动脉搭桥术(MIDCAB)用于前壁血运重建的围手术期及中期结果的比较分析
Innovations (Phila). 2017 May/Jun;12(3):207-213. doi: 10.1097/IMI.0000000000000378.
3
Robotic Totally Endoscopic Coronary Artery Bypass Grafting: Systematic Review of Clinical Outcomes from the Past two Decades.机器人全内镜冠状动脉旁路移植术:过去二十年临床结果的系统评价
Innovations (Phila). 2019 Feb;14(1):5-16. doi: 10.1177/1556984519827703.
4
[Clinical factors influencing surgical approach selection of robotic-enhanced minimally invasive coronary artery bypass grafting].[影响机器人辅助微创冠状动脉旁路移植术手术方式选择的临床因素]
Zhonghua Wai Ke Za Zhi. 2013 Nov;51(11):1016-20.
5
Is there an optimal minimally invasive technique for left anterior descending coronary artery bypass?左前降支冠状动脉搭桥术是否存在最佳的微创技术?
J Cardiothorac Surg. 2011 Mar 25;6:37. doi: 10.1186/1749-8090-6-37.
6
Graft Patency after Robotically Assisted Coronary Artery Bypass Surgery.机器人辅助冠状动脉搭桥手术后的移植物通畅情况
Innovations (Phila). 2019 Apr;14(2):117-123. doi: 10.1177/1556984519836896. Epub 2019 Mar 18.
7
Cost and Outcome of Minimally Invasive Techniques for Coronary Surgery Using Robotic Technology.使用机器人技术的冠状动脉手术微创技术的成本与结果
Innovations (Phila). 2018 Jul/Aug;13(4):282-286. doi: 10.1097/IMI.0000000000000537.
8
A systematic review of the safety and efficacy of distal coronary artery anastomotic devices in MIDCAB and TECAB surgery.微创冠状动脉旁路移植术(MIDCAB)和全内镜冠状动脉搭桥术(TECAB)中冠状动脉远端吻合装置安全性和有效性的系统评价。
Perfusion. 2016 Oct;31(7):537-43. doi: 10.1177/0267659115618004. Epub 2015 Nov 20.
9
Minimally invasive hybrid coronary artery revascularization.微创杂交冠状动脉血运重建术。
Ann Thorac Surg. 2008 Dec;86(6):1856-60. doi: 10.1016/j.athoracsur.2008.08.034.
10
Robotic off-pump totally endoscopic coronary artery bypass in the current era: report of 544 patients.机器人非体外循环全内镜冠状动脉旁路移植术在当前时代的应用:544 例患者报告。
Eur J Cardiothorac Surg. 2022 Jan 24;61(2):439-446. doi: 10.1093/ejcts/ezab378.

引用本文的文献

1
Endoscopic micro-invasive cardiac surgery: State-of-the-art.内镜微创心脏手术:最新技术水平
Turk Gogus Kalp Damar Cerrahisi Derg. 2024 Oct 30;32(4):355-366. doi: 10.5606/tgkdc.dergisi.2024.56934. eCollection 2024 Oct.
2
Totally Endoscopic Coronary Artery Bypass Graft: Systematic Review and Meta-Analysis of Reconstructed Patient-Level Data.全内镜冠状动脉旁路移植术:重建患者层面数据的系统评价与荟萃分析
Innovations (Phila). 2024 Nov-Dec;19(6):616-625. doi: 10.1177/15569845241296530. Epub 2024 Nov 20.
3
Totally endoscopic coronary artery bypass grafting: experience in 1500 patients.
全内镜冠状动脉旁路移植术:1500例患者的经验
Interdiscip Cardiovasc Thorac Surg. 2024 Sep 4;39(3). doi: 10.1093/icvts/ivae159.
4
Clinical Updates in Coronary Artery Disease: A Comprehensive Review.冠状动脉疾病的临床进展:全面综述
J Clin Med. 2024 Aug 6;13(16):4600. doi: 10.3390/jcm13164600.
5
Systematic review and meta-analysis of two decades of reported outcomes for robotic coronary artery bypass grafting.机器人辅助冠状动脉旁路移植术二十年报告结果的系统评价与荟萃分析
Ann Cardiothorac Surg. 2024 Jul 31;13(4):311-325. doi: 10.21037/acs-2023-rcabg-0191. Epub 2024 Jul 26.
6
Minimal-Access Coronary Revascularization: Past, Present, and Future.微创冠状动脉血运重建:过去、现在与未来。
J Cardiovasc Dev Dis. 2023 Jul 31;10(8):326. doi: 10.3390/jcdd10080326.
7
Comparative efficacy of eight therapeutic methods in the treatment of left main coronary artery disease: a Bayesian network meta-analysis protocol.比较 8 种治疗方法治疗左主干冠状动脉疾病的疗效:贝叶斯网状Meta 分析方案。
BMJ Open. 2022 Sep 6;12(9):e058886. doi: 10.1136/bmjopen-2021-058886.
8
A different technique for sutureless coronary bypass grafting.一种用于无缝合冠状动脉搭桥术的不同技术。
Interv Med Appl Sci. 2019 Oct 7;11(3):187-192. doi: 10.1556/1646.11.2019.23. eCollection 2020 Sep.
9
Robotic totally endoscopic coronary artery bypass grafting: It's now or never!机器人全内镜冠状动脉旁路移植术:机不可失!
JTCVS Tech. 2021 Apr 10;10:153-157. doi: 10.1016/j.xjtc.2021.03.037. eCollection 2021 Dec.
10
A World-First Surgical Instrument for Minimally Invasive Robotically-Enabled Transplantation of Heart Patches for Myocardial Regeneration: A Brief Research Report.一种用于微创机器人辅助心脏补片移植以实现心肌再生的世界首创手术器械:简要研究报告。
Front Surg. 2021 Oct 6;8:653328. doi: 10.3389/fsurg.2021.653328. eCollection 2021.